Cochrane Abstracts
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents – Assessment of Adverse Events in Non-randomised Studies: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432498/all/Methylphenidate_for_attention_deficit_hyperactivity_disorder__ADHD__in_children_and_adolescents_–_assessment_of_adverse_events_in_non_randomised_studies:_Cochrane_systematic_review.
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432498/all/Methylphenidate_for_attention_deficit_hyperactivity_disorder__ADHD__in_children_and_adolescents_–_assessment_of_adverse_events_in_non_randomised_studies:_Cochrane_systematic_review. Accessed February 9, 2025.
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432498/all/Methylphenidate_for_attention_deficit_hyperactivity_disorder__ADHD__in_children_and_adolescents_–_assessment_of_adverse_events_in_non_randomised_studies:_Cochrane_systematic_review
Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents – Assessment of Adverse Events in Non-randomised Studies: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432498/all/Methylphenidate_for_attention_deficit_hyperactivity_disorder__ADHD__in_children_and_adolescents_–_assessment_of_adverse_events_in_non_randomised_studies:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
ID - 432498
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432498/all/Methylphenidate_for_attention_deficit_hyperactivity_disorder__ADHD__in_children_and_adolescents_–_assessment_of_adverse_events_in_non_randomised_studies:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
